Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer

Allan LiptonMilton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA, USAAbstract: Bisphosphonates inhibit osteoclast-mediated bone resorption, thereby inhibiting the release of growth factors necessary to promote cancer cell growth, differentiation, and tumor formation in bone....

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Allan Lipton
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2011
Materias:
Acceso en línea:https://doaj.org/article/a5d614df33a3424abd4785a12817b187
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!